Update: February 18, 2026
The US FDA plans to drop its longtime standard of requiring two rigorous Phase 3 studies to win approval for new drugs. FDA Commissioner Dr. Marty Makary has co-authored a paper on this development that is titled: “One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma.” This was suggested as early as 2024 by Trump team insiders, and may finally come to fruition. Hopefully this benefits a number of hair loss products that are currently in Phase 3 trials in the US.
May 11, 2023
For many years, hair loss sufferers have dreamt of faster and cheaper clinical trials. I think that we are now close to doing so in the US. Some other countries have already streamlined the process, and they will get a competitive edge in new drug development.
A large number of companies never develop potentially effective hair growth products due to the prohibitively expensive costs and time involved in rigorous clinical trials. Others end up ceasing trials mid-way through due to the lack of funding.
Table of Contents
- Are prolonged clinical trials on the way out?
- Faster trials in Japan and the UK.
- Secretive China.
- Fast tracking of the mRNA vaccines and its major implications.
- AI and faster clinical trials.
- A list of the numerous mostly failed 10-year+ clinical trials in the hair loss world.
- No financial sense in even beginning clinical trials. Including for dutasteride and oral minoxidil.
- The FDA and its possibly intentional grey zone.
- The Cosmeceutical shortcut.
- The YOLO mentality, social media and increased risk taking.
- The 8 stages of clinical trials (rather than just 3).
Are Prolonged Clinical Trials on the way out?
According to CB Insights:
“Studies estimate that the clinical trial process — where new drugs are tested on patients before the FDA approves them — lasts 9 years.”
I have no doubt at all about this time-frame. For us hair loss sufferers, there have been numerous hair loss companies that have made us wait for 10-15 years while going through extensive three-stage trials.
If everything goes perfectly, the three stages of clinical trials can hypothetically be completed in 5 years. Plus another year for manufacturing, marketing and sales. However, in almost all cases, this does not seem to happen.
Most delays are due to fundraising issues after each stage of the trials. However, many delays just seem like intentional prolongation and stock price manipulation attempts.
Faster Clinical Trials in Japan and the UK
In 2014, I wrote a post on the pioneering initiative made by the Japanese government in fast tracking stem cell technologies in the regenerative medicine space. Their aging population cannot afford to wait ten plus years for new technologies to come to market. The new regulations would allow for significantly faster clinical trials.
A short time after the above news, HairClone’s CEO Paul Kemp told me that they were going to start their trials in the UK due to favorable regulations regarding in-clinic early use.
And just recently in March 2023, it was announced that Britain is set to overhaul clinical trial regulation to fast-track approvals.
“The move comes months after an industry report showed that the number of annual clinical trials started in Britain dropped by 41% between 2017 and 2021, posing a “clear and serious threat” to its reputation as a clinical research destination.”
Secretive China
I also suspect that Kintor Pharmaceutical is seeing faster clinical trial progression in China compared to the US, although I am not certain. The renowned case of the world’s first ever genetically modified babies in China in 2018 makes it clear that shortcuts are easier in that country.
Covid-19 mRNA Vaccines Fast Tracking
The Covid-19 mRNA vaccines were created, evaluated and authorized for emergency use in under a year. While mRNA vaccine research was already going on for a decade, this one year time-frame was insane. Even considering the scale of the global pandemic, I could not believe the speed with which all of this went down.
Even more astounding was how quickly over 60 percent of US residents accepted this new technology into their bodies. In my opinion, the year 2021 represented the turning point in how much risk people and governments were willing to take when it comes to new drug or vaccine development.
The COVID-19 pandemic also set in motion the increasing adoption of decentralized clinical trials. This entails bringing an increasing portion of a trial’s activities to the patient virtually. In contrast to bringing patients to a trial site, as has been the historical norm.
AI, Big Data, Organ-on-a-Chip and Faster Clinical Trials
With artificial intelligence (AI) in the news every single day in 2023, it is no surprise that AI is expected to significantly boost the speed of clinical trials. Last year, I wrote a post on AI and Machine Learning for hair loss drug discovery. When it comes to trials, companies can use AI to rapidly digitize clinical-trial processes so they can complete studies faster. According to a 2022 Deloitte survey:
“76% of respondents are currently investing in AI for clinical development.”
AI can also help in the recruitment, monitoring and retention of trial participants. Including via the use of wearable technologies and via remote videoconferencing and data collection.
Also related is the use of big data and analytics in making clinical trials better and faster. Moreover, organ-on-a-chip technology is coming of age and will boost the speed of drug development in the near future.
10-Year Clinical Trials in the Hair Loss World
In the hair loss world, we have seen many examples of companies taking ten or more years to finish clinical trials. In some cases, they even take ten years to get through Phase 2 trials, and then decide to not move forward.
Among the most well known examples of these frustrating long-term clinical trial scenarios in the hair loss world include the below. With few exceptions, most of these already failed or are likely to fail.
- Cosmo Pharma and its Breezula, which finally began Phase 3 clinical trials in 2023 after 10 years. The company changed its name and ownership structure in between. I am still hopeful that this androgen receptor (AR) targeting product will get released.
- The even slower and increasingly suspect Follica. They must have been at this for almost 15 years by now?
- And don’t even get me started on the 14 years we wasted following Histogen. It surprisingly folded after starting Phase 3 trials; then came back and went backwards to start Phase 1b trials (!); and then re-folded (!!). Hair loss sufferers are perhaps the most gullible group of people on earth.
- Samumed (now Biosplice) was supposed to be the miracle story in the entire world of dermatology. Their valuation levels reached astronomical levels. They even finished Phase 3 trials for their AGA product after a decade of being in the news. Including a cover story in Forbes starring their poker star CEO. Then the hair loss program folded.
- Replicel (Canada) and its partnership issues with the much larger Shiseido (Japan). I still have some hopes that Shiseido will come through with final stage trials. But I would not bet on this technology coming to market anytime soon.
- Dr. Takashi Tsuji and Riken (Japan)’s hair multiplication procedure. This was the single biggest disappointment for me since I started this blog ten years ago. But Dr. Tsuji is not out of the game yet and a previously announced 2020 release has now pushed forward to 2026. By now they should have been in Phase 3 trials, but persistent fundraising issues have delayed Phase 1 human trials.
- After major overpromise and hype, the hair multiplication failures of both Aderans and Incerytex over a decade ago.
- Follicum, which has come back again from the dead. However, I and most other readers suspect that all they will do is disappoint a second time.
- Setipiprant PGD2 antagonist. It was purchased by Kythera in 2015, which in turn was purchased by Allergan, which in turn was purchased by AbbVie. Ultimately, the product never came to market due to disappointing late stage trials. I still cannot get over this audio recording and the fact that it was never removed from the internet.
- Also of note is Aclaris Therapeutics, although they only wasted five years of our time.
- And I hope that Stemson Therapeutics does not turn out to be a dud. They have been in existence since 2017, but have yet to even commence Phase 1 human clinical trials.
No Financial Sense in Getting FDA Approval
In many cases, companies with effective hair loss products do not even try to begin rigorous expensive clinical trials in order to get FDA approval. i.e., they give up even before starting. Even large multinational drug manufacturers are reluctant to go for it, including for the two most popular hair loss products (off-label use) in existence today:
- The most egregious example of this is GSK’s decision to not file for FDA approval to market its enlarged prostate (BPH) reduction drug Avodart (dutasteride) for hair loss. To this day, dutasteride is only approved to treat male pattern hair loss in South Korea and Japan. Even though it has been proven to grow more hair than Propecia (finasteride) in almost all studies that compare the two.
- In all likelihood, blood pressure medicine oral Minoxidil will never undergo clinical trials for hair loss. The profit margins are too low, even though the drug is getting rave reviews from doctors and patients when it comes to its hair growth effects.
The FDA Intentionally Allows this Grey Zone
Below is a great interview of Dr. Jerry Cooley by Dr. Robert Haber. The former elaborates on the slow progress of FDA approvals and the tough job at hand for the FDA. It faces pressures from each side to go slower versus faster.
Dr. Cooley mentions exosomes as being one of those grey zone areas where he is glad to be able to use a reputable product, even though it is not FDA approved. Instead, the manufacturer’s lab is closely checked by the FDA to ensure that all regulations are strictly followed. Reminds me of the recent FDA delays in banning NMN supplements.
Key Dr. Cooley quotes from from 12:27 and 13:00:
“I personally believe that the FDA intentionally allows this grey zone…they actuallly want doctors to do some innovation”.
The Cosmeceutical Route Shortcut
The recent hype surrounding the extremely rapid development and sale of CosmeRNA portends favorably towards new future hair growth products. If a company can get approval to market a new product as a cosmetic, it entirely escapes the clinical trial process.
Even more interesting is the fact that you do not need this approval beyond one country or region to get going. Bioneer is not allowed to sell its product in its home nation of South Korea, but can do so in the UK and EU.
YOLO Mentality and Risk Taking
In my opinion, young people are increasingly becoming risk takers. Part of this is due to the “You Only Live Once” (YOLO) mentality. This is amplified by social media and the emulation of various influencers.
On Instagram, I am amazed to see the countless people who go through various laser, injectable and chemical treatment procedures on their faces. Many are easily influenced by celebrities, TikTok plus YouTube videos, and live real-time treatment demos from clinics.
Even crazier is people who take part in various Group Buys via hair loss forums, Discords and Reddit. They often import drugs and chemicals from sketchy entities in China and Eastern Europe. DIY gene therapy is also a thing.
Where I reside in the US, marijuana legalization has led to tens of thousands of new customers (and bad drivers). Fentanyl overdose deaths hit new records every year in the US. And US retail drug prescriptions are also at a record high. Illegal online drug purchases are probably also hitting new records each year.
I am not trying to make it all sound like doom and gloom. It just seems like people are willing to experiment with what they ingest or inject into their bodies more than ever before.
And I almost forgot. Global hair transplant surgery totals also hit a new record last year. You will probably see the same trend with many other cosmetic procedures. Partly due to the proliferation of Zoom and the work-from-home trend, which has made so many people insecure about their appearance.
Clinical Trials: In Reality, there are 8 Stages
When I asked ChatGPT to give me the various stages of the clinical trial process, I was expecting around 4-5. Instead, it gave me the below list of 8 steps. I have not even tried to check if all of the below is true to the dot, but it looks accurate.
It is quite clear that the current clinical trial process is antiquated by the standards and expectations of the modern age. And it is also evident that a revamp is in the works in many parts of the world.
Hate to say it boys but after all these last ten years it’s looking like Breezula will be the only new thing. A finasteride alternative is a bit of a W, I guess.
Just get a transplant if you’ve only receded a bit and other than that, your option is a piece. That’s all you’ve got.
Don’t be that guy.
Thanks so much, we needed this intellectual piece of advice. What would we do without that guy.
Tomorrow’s post will be a great one… and everyone needs to listen to this guy over that guy.
Goes without saying Admin, been a long time since That Guy chimed in, seems he’s thrown in the towel. Look forward to your next post.
Admin, you can’t tease us like this and then make us wait all day ;)
Am in the US west coast but will try to get it out before my 4 pm!
Just teasing. Looking forward to it, thanks!
As dermatologists, almost 80% of what we prescribe is “off label,” meaning we are prescribing it for something other than what it was originally approved for by the FDA. This is normal in our field, because hair loss and other dermatology complaints unfortunately are not prioritized the same way that more “important” medical problems are, like Heart Disease or Prostate Health (what hair loss medications like minoxidil and finasteride are actually approved for). And this isn’t even mentioning compounded medicines (like topical finasteride with minoxidil), which is not FDA-approved at all given these are made is small batches by compounding pharmacies rather than pharma companies… Anyway, these are things that dermatologists navigate everyday but there is a lot of reason to be enthusiastic if you want to treat hair loss in 2026 and in the near future!
Can you please cure hair loss for me?
Does this now mean PP405 will now only have one phase 3 trial instead of two?
My understanding is that since 1997, the FDA has had the discretion to accept “one adequate and well-controlled clinical investigation and confirmatory evidence” FDAMA (1997) / Section 115. The criteria for this is set out in the regulations. So while they have had the authority to accept only one trial, they have tended to default toward the more conservative 2 trial path. I believe this means that they are signaling a shift toward a deafult stance of requiring only 1 trial if it is well designed and it produces conclusive results. This is one of the reasons why a company will work with the FDA upfront on trial design…..which I believe Pelage says they are doing currently.
Yeah agreed. Afaik it is more about the quality and thoroughness of a trial instead of the plain number.
I was disappointed about the late start of phase 3, but Gil said they are closely collaborating with the FDA regarding trial design. In the past weeks they also hired two new senior staff members for trial organisation.
I think they are doing everything right. It would be ludicrous to rush it now and potentially eff it up.
I wasn’t sure where to put this, but it is a useful source to bookmark. Last updated by the US FDA on 8/15/25.
Only one approval so far is for a cosmetic purpose: LAVIV from Fibrocell for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.
US FDA Approved Cellular and Gene Therapy Products
https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products
Some relevant new developments in the US:
https://www.fda.gov/news-events/press-announcements/fda-announces-completion-first-ai-assisted-scientific-review-pilot-and-aggressive-agency-wide-ai
https://www.fda.gov/news-events/press-announcements/fda-announces-plan-phase-out-animal-testing-requirement-monoclonal-antibodies-and-other-drugs
https://www.citizen.org/news/jim-oneill-indicates-he-will-not-protect-the-american-people/
“For example, O’Neill previously suggested that the Food and Drug Administration should grant marketing approval to pharmaceuticals based solely on safety and without regard to whether they actually work.” I agree totally. Let the market determine if it works! It will save a ton of money and bring the cost down. Pelage should have already been approved for use!
Do we really want a ton of people with medical conditions taking sugar pills as treatment (those are safe with no efficacy)? For hair loss, fine, but think of progressive life threatening conditions that have good treatments (e.g. HIV) or even your run-of-the-mill chronic condition that are well managed with medication (e.g. diabetes, asthma). Uninformed people could cause irreparable damage to their bodies and shorten their lifespan because their doctor doesn’t tell them of the risks. Or they don’t understand the risks. That is not even including the insurance costs.
It wouldn’t mean all drugs would have to cease trials after demonstrating safety, just that ones perhaps for more severe conditions with poor prognosis get to the market quicker so people with limited time and options could try them. Manufacturers who want to demonstrate efficacy can still take that extra time and cost to do so (also perhaps gathering post marketing data for the same drug if it were approved following safety trials and had some real world efficacy data from people who started taking it).
I guess my point would still hold in that scenario. Any pharma company could take a flop drug and knowingly put it on the market for desperate people to try, charge a ton of money and it all be legal. It would be like all the snake oil we see for hair loss but just for many more health conditions and prescribed by doctors and paid for by our insurance. Why invest in something that has efficacy when I can just put out flop drugs and beef up marketing to uninformed consumers and lie/bride doctors to prescribe it? I mean technically pharma already does this with all the off label uses of the new drugs. Look at how many things GLP-1s, a diabetes drug, are used for now. Its not just weight loss but anything that is remotely caused or worsened by inflammation.
That being said, I can see value in dropping the second Phase 3 clinical trial in the scenario you’ve mentioned.
https://x.com/tsarnick/status/1882238097594916872
https://youtu.be/yr0GiSgUvPU?si=sasobsQS7_y_6eY8
Fascinating Interview of Hassabis, one of the great minds of our time.
Maybe Trump can create a Department of Pelage!
Trump was President before and nothing happened…
Other countries already speeded up the trails and we still have no cure.
They both could already have spent billions on hair loss research but they still haven’t done that.. so let’s wait for results before creating hope.
@Jens: Trump learned a lot from his first stint, which is why you’re already seeing a lot of changes, such as DOGE.
Jens, the only countries that are doing a large number of things in hair are the US (by far the number 1), South Korea and Japan. Perhaps China too, but unclear.
This probably applies to all clinical research (and arguably innovation in general, at least for the US)
Superb post and update.
Interesting recent letter from Shinya Yamanaka. He is the winner of the 2012 Nobel Prize in Physiology or Medicine for generating induced pluripotent stem (iPS) cells.
https://japannews.yomiuri.co.jp/editorial/insights-world/20230407-102052/
“Our endeavor for the medical application of iPS cells is set to enter the second half of the race when the real competition begins. We would like Japan to be at the vanguard of the world in realizing iPS cell-based medicine to help many patients awaiting new treatments.”
This is an excellent post and effort Admin.
I am curious if Chinese clinical trials even take more than 5 years?
OT here: Triple Hair of Canada had been planning Phase III trials (US included) for its Minox + Fin + Latanoprost combo. Their Phase III trial had been delayed…and delayed. I’m not sure if it’s still on for 2023, but they are now selling their product at an online pharmacy as a compound. They mention the hair might become darker….I’m trying to remember if latanoporst was one of the compounds that was found to darken grey hair.
There is a study about latanoprost and hair repigmentation after 3 years treatment. What’s the online pharmacy called where they are currently selling?
HairStim can also add Latanoprost. See bottom of this post:
https://www.hairlosscure2020.com/topical-finasteride/
Per a comment from Yoda, Formula 82D (made by the same company as Formula 82F that I listed in the above link) can also include Latanoprost.
I suspect that a few of these topical finasteride compounders can add Latanoprost into the mix if desired.
Hey admin, Great post! A bit off-topic, but have you thought of renaming the website to Hairlosscure2030? ;)
That is the most common recommendation for improvement that I get for this site :-)
Well, judging by how things are progressing it looks more and more likely that we’ll have some decent treatments by the end of this decade. They might not be real cures (for that we may have to wait til 2040, if we’re lucky), but much better treatments that the stuff we’ve got right now.
So would you do it? It’s not bothering me at all, I am just curious. :)
No, I am going to be done and dusted before 2030! And I do not want to rename the site.
A bit of a mix up Admin, the pharmacy (Anazao Health) I was getting the 82D from had a separate product that I used with Lantaprost in it called Phytosol. This also had minox and spiro in it as well. 82D in the AM/Phytosol in the PM. I quit using their products as they had issues with the 82D coming out of suspension, crystals forming. Not to mention they are very expensive. I went back to the stuff I was using before, less money and similar ingredients. I can tell you guys that Lantaprost or Bimatoprost has done zero for my grey hair.
Thanks for the clarification Yoda.
Can’t we ask Joe Rogan to talk to the c.e.o of Dnovo or stemsons therapeutics or junji Fukuda or Dr tsuji if he’s not to busy doing witchcraft ?
The real “cure“ will be drug that will stop the hair loss at very early stage and give you some regrowth, so you can maintance your hair for years and years without side effects. And it will be cheap to buy it. That is the perfect solution and younger generations will have it in next 10 years.
Most of the guys who are visiting this website are in advanced stage of AGA, so for them “cure“ is some treatment that will give them full head of hairs. That solution is maybe 15 years at least away for ordinary Joe. Even it is out on the market it will take more than a decade to come to your dermatology doctor. Stem cell/iPSCs therapies will require highly trained doctors/professionals. All those technologies will be new and very complicated, so limited number of doctors and clinics will perform it. And that means only limited number of patients will get it next decade. So, pills are far less complicated solution for hair loss, but all treatments involving pills, topicals, injections will have very limited results for most of the people.
Add Stemson Therapeutics to the list. They’ve been at it since 2018 and seem to be going nowhere. They report no new news other than hires to their team or management. They’ve been doing pig trials starting the beginning of 2021 and haven’t reported their findings. Their CEO has no clue when anything will get off the ground and has no interest in catering to anyone who isn’t a news maker. Probably will be a pre-clinical company until they fold like all the rest of them. People come and go from this outfit.
Another likely dud is DNovo. They grew hair on human skin grafted onto a mouse in 2020 and since then nothing to report. They too started in 2018.
Then hair was actually cloned in 2015 and grew on human scalps but not in the right direction. Since then we haven’t been able to solve this? WTF? We have biodegradable scaffolding now, so why not try it again in this way so the hairs can grow in the proper direction?
Of course we don’t want to discourage people from trying but sick and tired of all the news and false claims that hair loss has been solved with no workable solutions.
How many more years of this crap will be going on? Will it be 30 years in the future before this is figured out? All this technology we have today but can’t grow hair properly on humans once it’s lost. Sheesh! At this rate humans will colonize Pluto before we get a hair loss cure.
Stemson literally had a seminar where they want to commence human trials next year…
Where did you get this information?
Admin Edit: I updated the link to archive.
https://web.archive.org/web/20221126233142/https://wxpress.wuxiapptec.com/geoff-hamilton-co-founder-ceo-stemson-therapeutics/
It was on this website but the page looks like its been taken down. Trust it, they wouldn’t be continuously hiring new employees if they were a failing biotech company. Just like in life you can’t be too optimistic or too pessimistic, you gotta see things for what they are. Stemson is looking like they’re on the right track so let’s wait and see what they bring to the table. I do believe we’ll have something exciting in terms of news 3/4 quarter of this year. But I’d personally be more excited for Epibiotech considering they are doing clinical trials this year and have a faster clinical process (estimate market release date 2026/2027). Plus Stemson has said they will consider Japan/UK/South Korea for clinical trials where the process will be a lot faster compared to the USA.
https://www.scienceboard.net/index.aspx?sec=cgt&sub=def&pag=dis&itemId=4909 over here geoff says a couple of years is when they feel ready and a scientist on the inside said that there have been insane results in the lab.
https://www.businesswire.com/news/home/20230201005196/en/Kevin-D%E2%80%99Amour-PhD-Joins-Stemson-Therapeutics-as-Chief-Scientific-Officer
I never heard any of this. Do you have a link to this information you could provide?
But I have provided multiple links in the comments I previously made?
Added Stemson, with a caveat. Have covered them in many posts and even interviewed Dr. Terskikh in the past, but they are moving way too slowly.
New scientific paper by the guys from Epibiotech about their pig trials. Check it:
https://onlinelibrary.wiley.com/doi/10.1111/exd.14795
Good find Bryan! We need someone to break this down for all us please.
It is very strange that in 20 years we didn’t see 1 picture before/after from all companies.
And they have bald CEOs.
We live in happy times that nobody can sell you scam treatments anymore.
It’s ridiculous that during Covid drugs for all human beings were tested for only one month and a hair drug must be tested for 10 years.
Everything over 3 years testing is not acceptable..
All of these companies failed all 50 of them the past 23 yrs. Nothing will work ….sorry. get an fue and pray big 3 lasts…it’s just reality.
Guys, you must understand that the clinical trials are not the main problem. Poor perfomance by the companies in pre-clinical trials are the main problem.
Last decade we learned a lot about the mechanism behind Androgenic Alopecia and structure of hair follicles. Just to remind you that 15 years ago we didn’t even know how to properly isolate dermal papilla cells in mice. We are long way from credible solution for hair loss. That is reality. Stem cells/iPSCs are very promising technology, but still very expensive and robust, and need to overcome some limitations like robust and cheap manufacturing, cheap materials, control the quality of stem cells. There are many new technologies on the way in different areas of science, but they are still far away from clinical applications.
At least ten companies that I/we followed for most of the past 10 years. Without lengthy clinical trials, I would have half the content on this blog.
90% of companies that you covered on this blog dissapeared after 1 or 2 years. What all they have in common is fancy website, fancy team, fancy scientific words, bald CEOs, no before/after photos.
Other 10% of companies that you are covering got results similar or worse than Finasteride in Phase I .
Reality is that we must stick to big 3 in next 10 years.
Way off. I even listed 10 long-term ones in this very post and there are more. You think I covered another 90 plus companies that disappeared after 1 or 2 years?
Admin is there a way to turn off comments from people who just parrot the same nonsense over and over and over again? It’s just wasting time and there’s no new input from these characters not quite sure why they stick around forums and start moaning if they’re filled with that much despair.
Unfortunately not. We get one of those people every few months it seems. I will disallow repetitive comments from this latest guy. I noticed that he made the bald CEOs comment in 4 prior comments.
Sounds good
Excellent piece admin. It’s a shame what appears have happened with follica, although part of me hopes that they’ve bought puretech out and will shortly be announcing plans for coming to market.
Still, if niostem’s figures are real (they said on their Indiegogo comments that they’re publishing them), then it’s problem solved basically and all these AR pathway meds are dead in the water.
Appreciate all the effort you put into this admin. 5 gold stars from ol Summy here. As a footnote: I’ve said this a thousand times before…if it ain’t on the shelf, it doesn’t exist – (yet). These company’s remind me of little sea turtles all scrambling to the shoreline, desperate to make it before being snatched up by swooping gulls (ie, other company’s). Then the odds of them surviving in the ocean (ie, the market) are very small. Only a few ever make it.
I think someone has put something in my coffee?!
CosmeRNA bucked the trend! Maybe Kintor will too. Though both unlikely to be better than Finasteride.
Do they need to be better? They could be adjunct treatments and perhaps the results compound?
True.
Where’s Summy Kim? Too many crucifixes? Summy your insight, wisodom and philosophy are missed.
A shot of crucifix in your coffee, maybe Summy?
For sure mate. When I start rambling about sea turtles of all things, and then comparing them to the hair loss industry – I think a little Crucifixion mixed in with the coffee beans is well in order.
Admin this report is brilliant it deserves to be in people magazine! Kintor is just another finasteride though.
Thanks. I got my once a decade compliment from Marc!
I still don’t hold much hope for faster clinical trials. We have had fast track in Japan for some years now and still nothing particularly good has come for us as a result.
Pretty dissapointment results from Kintor.
Too much hype for nothing. Let’s stick to big 3 and get back in 10 years from now.
Voluntary announcement – successful completion of phase II clinical trial of KX-826 for treatment of AGA in the United States.
I agree Bryan, but whether the product is good or bad, the trial process shouldn’t take as long as it does. If it’s bad, the trial will prove it.
But we’re not just talking about hair loss drugs (though on this site that’s what we’re most interested in – myself included). Speeding up this process will help for other drugs and illnesses as well.
I’m glad they’re finally realizing it. I understand why we have rules and regulations (and I’m grateful for them – safety first) but processes should be analyzed every few years to determine if they’re all still needed and if changes can or should be made. Basically, screw the old adage of “if it ain’t broke don’t fix it.” Some things aren’t exactly broke (per se) but aren’t exactly a well oiled machine either and could use some added efficiencies, changed or even a total overhaul.
Clinical trials are not always the main problem. Vast majority of companies has scum products.
Hair loss is far more complicated disease than we might think.
We will have virtual clinical trials simulating millions of humans for drug testing in 2035 or after. They will be 1000x cheaper and will be done in weeks/months rather than a decade. Now the problem is the FDA.
Haha, that would be very interesting and perhaps worthwhile. The challenge would be generalizability in that case; to what extent do results in virtual humans translate to actual humans? Kinda like how results in mice translate to humans.